We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 84

Full Court warns against dangerous affliction of parameteritis (and confirms invalidity of aripiprazole patent)
  • King & Wood Mallesons
  • Australia
  • August 26 2016

On Wednesday the Full Court of the Federal Court of Australia handed down a decision in which it upheld Justice Yates' findings that Otsuka's patent


High Court re-invents the test for patentable subject matter and finds the patent for the isolated breast cancer gene invalid
  • King & Wood Mallesons
  • Australia
  • October 8 2015

The High Court has handed down a significant decision finding that patent claims for isolated gene sequences, indicative of a predisposition to


High Court finds patent for isolated breast cancer gene invalid and re-invents test for patentable subject matter
  • King & Wood Mallesons
  • Australia
  • October 8 2015

The High Court has handed down a significant decision finding that patent claims for isolated gene sequences, indicative of a predisposition to


High Court states the obvious: AstraZeneca AB v Apotex Pty Ltd appeal decided
  • King & Wood Mallesons
  • Australia
  • September 3 2015

In a widely anticipated decision, the High Court has upheld a decision of the Full Federal Court (which was made by five, rather than the usual three


Otsuka successful in stay application: Otsuka Pharmaceutical Co., Ltd v Generic Health Pty Ltd 2015 FCA 848
  • King & Wood Mallesons
  • Australia
  • August 26 2015

Further to our post of 7 July 2015, the proceedings brought by Otsuka and Bristol Myers Squibb (the "exclusive licensee" of Otsuka's patents for


Generic Health succeeds in invalidating patent for aripiprazole: Otsuka Pharmaceutical Co., Ltd v Generic Health Pty Ltd (No 4) 2015 FCA 634
  • King & Wood Mallesons
  • Australia
  • July 7 2015

Generic Health is perhaps a step closer to bringing its generic version of the antipsychotic drug aripiprazole to market in Australia after Justice


Vision Eye Institute Ltd v Kitchen (no 2) 2015 QSC 66
  • King & Wood Mallesons
  • Australia
  • July 2 2015

In this case, the Queensland Supreme Court awarded a significant amount of damages for contingent loss of income flowing from a breach of contract


Food law: quick bites and upcoming calendar
  • King & Wood Mallesons
  • Australia
  • April 30 2015

The ACCC is seeking leave to appeal the Federal Court decision dismissing its case against Pfizer for alleged misuse of market power and exclusive


Privacy Commissioner’s decision set aside by the Federal Court
  • King & Wood Mallesons
  • Australia
  • March 16 2015

A recent decision by Federal Court of Australia illustrated two things about privacy complaints - or at least those that end up before the courts:


De-identification and medical records in NSW
  • King & Wood Mallesons
  • Australia
  • October 24 2014

Are health service providers in New South Wales obliged by the Health Records and Information Privacy Act 2002 (NSW) to de-identify medical records